Form 8-K FRACTYL HEALTH, INC. For: Jul 15
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/30/2026
- Crude Inventory Fell 7.2 Million Barrels Last Week - EIA
- SoFi Technologies (SOFI) Tops Q2 EPS by 1c ; Offers Guidance
- Wall Street closes down sharply after Fed holds rates unchanged
- Grant Thornton Advisors to buy CBIZ in $5 billion deal, expand US accounting reach
- How will the S&P 500 react to today’s FOMC? JPM lays out the playbook
- After-Hours Stock Movers: META, MSFT, CMG, SBUX, CVNA, LRCX, FTNT, QCOM, TDOC
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
- After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK
- After-Hours Stock Movers: GOOGL, TSLA, NOW, IBM, TXN, MOH, URI
H.C. Wainwright Reiterates Buy Rating on Fractyl Health Inc (GUTS)
July 15, 2026 12:16 PM EDTH.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating and $8.00 price target on Fractyl Health Inc (NASDAQ: GUTS).
The analyst comments "Overall, we believe that REMAIN-1 midpoint cohort data demonstrate Revita-mediated durable and substantial weight retention at one year without the need for ongoing medication. We expect these observations to be reproduced and valudated in the ongoing, larger pivotal cohort of patients. Topline six-month randomized data are... More
